Independent medical communications agency Integrated Medhealth Communication (IMC) has acquired Toronto-based Script Medical Writing as part of the expansion plans for its North American office.
London-headquartered IMC is looking to the deal to boost its scientific writing expertise and talent as well as bring what it says will be a significant number of new pharmaceutical and biotech clients.
Shairose Ebrahim, founder and CEO of the IMC group, said: “I am delighted to welcome the Script team to IMC NA. This acquisition is a testament to our unprecedented growth and success in the North American market and will strengthen our position as a leader in scientific communications globally.”
Script was established in 1998 and has developed medical content including peer-reviewed journals and abstracts, posters and presentations for international congress across multiple therapy areas.
“Increasing our scientific writing expertise through Script, combined with our capabilities in developing innovative medical communications solutions, will provide added value to our clients and enable us to help them achieve greater success with their brands and communication programmes,” said Dr Azhar Rana, vice president and managing director of IMC North America.